Literature DB >> 28597373

Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research.

Axel C Mühlbacher1, F Reed Johnson2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28597373     DOI： 10.1007/s40271-017-0249-5

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  9 in total

1.  Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.

Authors:  Axel C Mühlbacher; Anika Kaczynski
Journal:  Appl Health Econ Health Policy       Date:  2016-02       Impact factor: 2.561

2.  Health Preference Research: An Overview.

Authors:  Benjamin M Craig; Emily Lancsar; Axel C Mühlbacher; Derek S Brown; Jan Ostermann
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

Review 3.  Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature.

Authors:  Kevin Marsh; Tereza Lanitis; David Neasham; Panagiotis Orfanos; Jaime Caro
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

4.  Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice.

Authors:  Axel Mühlbacher; F Reed Johnson
Journal:  Appl Health Econ Health Policy       Date:  2016-06       Impact factor: 2.561

Review 5.  Role of patient and public participation in health technology assessment and coverage decisions.

Authors:  Devidas Menon; Tania Stafinski
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-02       Impact factor: 2.217

6.  The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options.

Authors:  Axel C Mühlbacher; Andrew Sadler
Journal:  Value Health       Date:  2017-02-16       Impact factor: 5.725

7.  Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare.

Authors:  James G Dolan
Journal:  Patient       Date:  2010       Impact factor: 3.883

8.  Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.

Authors:  Axel C Mühlbacher; John F P Bridges; Susanne Bethge; Ch-Markos Dintsios; Anja Schwalm; Andreas Gerber-Grote; Matthias Nübling
Journal:  Eur J Health Econ       Date:  2016-02-04

9.  Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues.

Authors:  Axel C Mühlbacher; Peter Zweifel; Anika Kaczynski; F Reed Johnson
Journal:  Health Econ Rev       Date:  2016-01-29
  9 in total
  9 in total

1.  Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

Authors:  David John Mott
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

2.  Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany.

Authors:  Matthias Herpers; Charalabos-Markos Dintsios
Journal:  Eur J Health Econ       Date:  2018-04-25

3.  Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments.

Authors:  Karen M Facey; Nicola Bedlington; Sarah Berglas; Neil Bertelsen; Ann N V Single; Victoria Thomas
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

4.  Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia.

Authors:  Axel C Mühlbacher; Andrew Sadler; Franz-Werner Dippel; Christin Juhnke
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

5.  Quantified patient preferences for lifestyle intervention programs for diabetes prevention-a protocol for a systematic review.

Authors:  Charalabos-Markos Dintsios; Nadja Chernyak; Benjamin Grehl; Andrea Icks
Journal:  Syst Rev       Date:  2018-11-29

6.  Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.

Authors:  D Cornelissen; A Boonen; S Bours; S Evers; C Dirksen; M Hiligsmann
Journal:  Osteoporos Int       Date:  2019-10-12       Impact factor: 4.507

7.  Research as an event: a novel approach to promote patient-focused drug development.

Authors:  Jui-Hua Tsai; Ellen Janssen; John Fp Bridges
Journal:  Patient Prefer Adherence       Date:  2018-05-03       Impact factor: 2.711

8.  Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.

Authors:  Rosanne Janssens; Eline van Overbeeke; Lotte Verswijvel; Lissa Meeusen; Carolien Coenegrachts; Kim Pauwels; Marc Dooms; Hilde Stevens; Steven Simoens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-10-11

9.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.